Cancer Treatments

Proteomics assays provide insight into cancer disease and treatment response, allowing for potent and durable therapies

Side effects of PI3Kδ immunotherapy could be mitigated by changing drug dosing

Radioisotopes linked to the same ligand allow for visualization and destruction of cancer cells

Germline BRCA testing continues to be underutilized, even for people with commercial insurance

The sensors are activated by proteases, triggering the release of signaling reporters that concentrate in the urine

The new guidance will help target treatments and address inequities by including all patients

Almost 30 years later, can researchers overcome the limitations of cancer nanomedicine and realize its potential?

New study finds blood biomarkers that help indicate the effectiveness of immune checkpoint inhibitors

Report emphasizes the need to fortify public health and medical research to improve cancer care during the pandemic

Four out of five cancer therapies tested in Phase III trials do not achieve meaningful benefit in prolonging survival